CD44 and gastric cancer: Loss of CMG2 significantly reduced the expression of the GCSLC marker CD44 and the stemness-related transcriptional factor SOX2 (Fig. 4a) as well as the proportion of CD44+ cells (Fig. 4b) in GC cells.